Outdoor electronic goods producer Sonim Technologies has filed for a $57.5m initial public offering that would provide exits for Motorola Solutions and JVC Kenwood.

Eli Lilly and GSK-backed precision oncology drug developer Turning Point Therapeutics floated at the top of its range while expanding the number of shares it issued.

Alexandria Real Estate Equities-backed molecular therapy developer Applied Therapeutics is aiming for $86.3m in its initial public offering.

Willow Biosciences is the result of a three-way merger between University of Calgary spinout Epimeron, BioCan Technologies and CSE-listed Makena Resources.

Microelectronics Technology Laboratory spinout Smart Force Technologies’ mask-less 2D microfabrication technology will be integrated with new 3D printers developed by Microlight3D.

Qualcomm, SanDisk and Mail.ru are among the investors exiting video-editing tool provider Magisto, which has agreed to an acquisition by Vimeo.

The biopharmaceutical company, formerly known as Pronutria Biosciences and backed by Nestlé Health Science, has filed for an $86.3m offering following $172m of funding.

Walmart will absorb Polymorph's native advertising technology following an acquisition that will involve Rakuten and MDC Partners exiting.

Pfizer is the largest shareholder of Alzheimer's drug developer Cortexyme, which has filed to raise up to $86.3m in its initial public offering.

The digital payment technology provider has been acquired by Naspers subsidiary PayU in a $70m deal that will enable Intel Capital to exit.